» Download Public Reports
51 reports
- Company report
- October 2012
- 28 pages
- by Corporation
... Double digit growth market ngs market has a big impact in the isothermal dna amplification market: for many technologies you need to amplify the complete dna before sequencing can begin qiagen wants ...
May 2012
... Genome network to provide access to whole-genome sequencing services. Walt disney rose on higher earnings expectation due to several drivers such as park expansion, film hits, new networks ...
July 2012
... Propose to combine the genetrix' dna sequencing subsidiary x-pol biotech and sygnis. Goal is to develop and market x-pol biotech, s.L.'S dna sequencing technologies and products. Sygnis will acquire 100 ...
June 2011
... cell lines, zebrafish embryo, toxicogenomic) to study the bioavailability and risk assessment of pahs and heavy metals in processed food products, using smoked meat sausage and cooked edible crab ...
May 2011
... The mentor: institute for bioengineering of catalonia cellular biotechnology microbial technology and host-pathogen interaction molecular and cellular neurotechnology control of stem cell potency ...
July 2011
... Approaches. Even when obtained in soluble forms, proteins tend to aggregate, especially if stored and manipulated at high concentrations, as is the case of protein drugs for human therapy. Post ...
January 2012
... In the cell therapy market, to enable completion of on-going clinical trials as well as the subsequent release of cell therapy products to the international market. For further details contact: saurabh ...
May 2012
... Of faster and safer diagnostic kits and techniques biotechnological drugs and vaccines capable of generating improvements in multiple diseases such as diverse types of cancer, alzheimer, multiple sclerosis ...
May 2012
... This provisional pdf corresponds to the article as it appeared upon acceptance. Fully formatted pdf and full text (html) versions will be made available soon. Packaging protein drugs as bacterial ...
October 2011
... cytokines was proposed as a strategy for early detection of immunotoxicity (pallardy et al., 1998). Studies in rats have shown that administration with mdma increases the secretion of th1-type cytokine il-2 ...
» Purchase Premium Reports
(From $ 125 - $ 750)
27 reports
- $ 750
- Company report
- May 2013
- by Global Data
Summary TiGenix NV (TiGenix) is a biomedical cell therapy company. The company specializes in the development of innovative local treatments for damaged and diseased tissues. It mainly focuses on the therapeutic ...
April 2013
$ 250
Summary 3P Biopharmaceuticals S.L. (3PB) is a contract manufacturing organization, based in Spain. The company manufactures biopharmaceutical products. It produces therapeutic proteins for laboratories ...
March 2013
$ 250
Summary Oryzon Genomics (Oryzon) is a biotechnology company, based in Spain. It develops diagnostic and therapeutic products for the healthcare markets. The company markets its products through its brands ...
May 2013
$ 125
Summary Ipsen Biopharmaceuticals, Inc., (Ipsen), formerly known as Tercica, Inc., is a biotechnology company. It identifies and commercializes products in therapy areas such as, endocrinology and neurology. ...
